Sheila A. Alexander, PhD, RN
Associate Professor, School of Nursing
University of Pittsburgh
Omics of Recovery from aSAH
Sepideh Amin-Hanjani, MD
AHA/ASA guidelines form management of SAH
Hemant Bhagat
Professor, Div. of Neuroanaesthesia
PGIMER, Chandigarh, India
aSAH and Anaesthesia: Current Understanding
Spiros Blackburn, MD
UT Health Houston
Haptoglobin genetics and outcome after SAH
Orestis Briasoulis, MD
Sr. Director, Global Medical Affairs, Idorsia Pharmaceuticals
Hon. Lecturer, Dept. of Experimental & Translational Medicine, University College London
Clazosentan: Where are we now?
Ketan R. Bulsara, MD
Professor and Chief, Neurosurgery
Director Neurosurgery Residency Program
Director of Operating Room Quality
University of Connecticut
The intra-arterial vasospasm trial
Diederik Bulters
Professor of Neurosurgery
University Hospital of Southhampton
A genome wide association study of the determinants of outcome after SAH
Aichi Chien , PhD FAHA
Professor, Physics and Biology
Division of Interventional Neuroradiology
Ronald Reagan UCLA Medical Center
David Geffen School of Medicine
Longitudinal Changes in Human Brain Aneurysms
H. Alex Choi, MD
Vice Chair of Neurosurgery, Critical Care
University of Texas, Houston
Director of Neurocritical Care, Memorial Hermann Hospital
Biomarkers of Cerebral Edema after Subarachnoid Hemorrhage
Sherry Hsiang-Yi Chou, MD, MSc, FNCS FCCM
Chief, Division of Neurocritical Care
Associate Professor
Northwestern Feinberg School of Medicine
MicroRNA Endotypes in SAH
Elisa Cuadrado-Godia, MD, PhD
Neurvascular Research Group
Hospital del Mar Medical Research Institute
Barcelona
GWAS and vasospasm and DCI
Anthony Delaney, MBBS, MSc, PhD
Associate Professor
University of Sydney
The future of clinical trials for aSAH: Where should we stand?
Lachlan Donaldson, MBBS (Hons), MPhil, FCICM
Intensive Care Specialist
PhD Candidate, The George Institute for Global Health, UNSW, Sydney
The reported incidence of cerebral arterial vasospasm following aneurysmal subarachnoid haemorrhage is highly variable, and a consensus definition is required: A systematic review and meta analysis
Jens P. Dreier, MD, PhD
Professor
Center for Stroke Research
Berlin
Brain discharge-1
Nima Etminan, MD
Professor of Neurosurgery
Universitatsmedizin Mannheim
Mannheim, Germany
Risk factor modification as a therapeutic target in unruptured intracranial aneurysms
Wayne Fang, MD
Professor of Neurology
Duke University
The road to recovery post aSAH
Soichiro Fujimura, PhD
Asst. Professor, Mechanical Engineering
Tokyo University of Science
Researcher, Dept. of Innovation for Medical Information Technology
Jikei University School of Medicine
Ian Galea, MD, PhD
Professor,
University of Southampton
Hemoglobin and haptoglobin: from basic science to clinical implications for SAH
Aaron M. Gusdon, MD
Asst. Professor, Neurosurgery
University of Texas Health Science Center
Systemic metabolic alterations after aneurysmal subarachnoid hemorrhage
David Hasan, MD, MSc
Professor of Neurosurgery, Duke University
iSPASM -1
Tomoki Hashimoto, MD
Professor of Neuro-Anesthesiology & Neurobiology
Barrow Neurological Institute
Translational Research of Intracranial Aneurysm
Isabel Charlotte Hostettler, MD, PhD
Neurosurgery Consultant
Canton Hospital, St. Gallen, Switzerland
Influenceable factors in aneurysmal subarachnoid hemorrhage: Is there a light at the end of the tunnel after all?
Michael Hugelshofer, MD/MSc
Attending Neurosurgeon/Research Group Leader Neurosurgery
Universitätsspital Zürich
CSF-Hemoglobin after aSAH: Biomarker and therapeutic target
Behnam Rezai Jahromi, MD
Neurosurgeon
Helsinki University Hospital
Vasospasm and shunt dependency with active CSF exchange
Jin Pyeong Jeon MD, PhD
Associate Professor
Hallym University College of Medicine
Beyond genetics: haptoglobin alpha isoform expression and outcome after SAH
Jingfeng (JJ) Jiang, PhD
Professor of Biomedical Engineering
Michigan Technological University
Artificial-intelligence-augmented computational hemodynamic analysis of intracranial aneurysms
Yong Jiang, MD, PhD
Professor of Neurosurgery
Southwest Medical University
Disequilibrium of metabolic homeostasis after SAH
Naoki Kaneko, MD, PhD
Assistant Professor
Interventional Radiology
UCLA Health
How do endothelial cells respond to flow in cerebral aneurysms? Bridging computational flow dynamics and endothelial biology
Emanuela Keller, MD
Associate Professor and Head of Neurocritical Care Unit
University Hospital Zurich, Switzerland
Prediction and Detection of Delayed Cerebral Ischemia in High-Grade SAH Patients
Daniel Laskowitz, MD, MHS
Professor and Vice Chair of Neurology
Director, DCRI Neuroscience Medicine
Duke University
Selective NMDA inhibitors in high risk aSAH: Neuroprotection revisited
Wonjae Lee, PhD
Assistant Professor of Neurosurgery
Duke University
Microfluidic Neurovascular Unit Model for Precision Medicine